TITLE

LYMPHATIC LEUKEMIA COMPLICATED BY CARCINOMA OF THE STOMACH

AUTHOR(S)
Brenner, Abraham J.; Epstein, Bernard S.
PUB. DATE
February 1956
SOURCE
American Journal of Gastroenterology;Feb1956, Vol. 25 Issue 2, p116
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the study on lymphatic leukemia complicated by carcinoma of the stomach. Anticipation on the increase of leukemia and carcinoma coexistence; Implication of chronic lymphatic leukemia especially on older people; Characteristic behavior of chronic lymphatic leukemia when complicated by carcinoma; Recession of leukemia upon the advancement of gastric cancer.
ACCESSION #
18669910

 

Related Articles

  • Early immune disruption may lead to CLL. Adams, Stacey L.; Harris, Jason; Lawrence, Leah // Hem/Onc Today;5/25/2009, Vol. 10 Issue 10, p23 

    The article reports on the findings of a research on association between skewed free light chain and late-stage development of chronic lymphocytic leukemia, presented at the annual meeting of the American Association for Cancer Research held in Denver, Colorado from April 18 to 22, 2009.

  • Complement values in B chronic lymphocytic leukemia: prognostic significance and correlation with cell maturation stage. Shvidel, L; Vorst, E; Berrebi, A // Leukemia (08876924);Apr98, Vol. 12 Issue 4, p635 

    Focuses on the prognostic significance of complement values in B chronic lymphocytic leukemia and its correlation with cell maturation stage. Evaluation of C3 and C4 serum complement levels; Significant decrease in the levels of C3 and C4 during the course of disease; Significance of the serum...

  • Ofatumumab-based chemoimmunotherapy effective in CLL.  // Hem/Onc Today;11/25/2013, Vol. 14 Issue 22, p26 

    The author comments on a study by Tait D. Shanafelt et al and published in a 2013 issue of "Cancer," which found that an ofatumumab-based chemoimmunotherapy is similarly effective as a rituximab-based regimen in previously untreated patients with chronic lymphocytic leukemia (CLL).

  • NF-?B2/p100 induces Bcl-2 expression. Viatour, P; Bentires-Alj, M; Chariot, A; Deregowski, V; de Leval, L; Merville, M-P; Bours, V // Leukemia (08876924);Jul2003, Vol. 17 Issue 7, p1349 

    The NF-κB2/p100 and bcl-3 genes are involved in chromosomal translocations described in chronic lymphocytic leukemias (CLL) and non-Hodgkin's lymphomas, and nuclear factor kappaB (NF-κB) protects cancer cells against apoptosis. Therefore, we investigated whether this transcription factor...

  • BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Romano, M F; Festa, M; Pagliuca, G; Lerose, R; Bisogni, R; Chiurazzi, F; Storti, G; Volpe, S; Venuta, S; Turco, M C; Leone, A // Cell Death & Differentiation;Mar2003, Vol. 10 Issue 3, p383 

    Cell Death and Differentiation (2003) 10, 383-385. doi:10.1038/sj.cdd.4401167

  • Spontaneous Remission in Chronic Lymphocytic Leukemia. Chervenick, P.A.; Boggs, Dane R.; Wintrobe, M.M. // Annals of Internal Medicine;Dec67, Vol. 67 Issue 6, p1239 

    Focuses on an apparent spontaneous and prolonged remission in a patient with typical findings of chronic lymphocytic leukemia, which began 18 months after cessation of all therapy. Result of the physical examination of the patient; Summary.

  • Matriptase is highly upregulated in chronic lymphocytic leukemia and promotes cancer cell invasion. Gao, L; Liu, M; Dong, N; Jiang, Y; Lin, C-Y; Huang, M; Wu, D; Wu, Q // Leukemia (08876924);May2013, Vol. 27 Issue 5, p1191 

    A letter to the editor is presented regarding the role of matriptase in chronic lymphocytic leukemia (CLL) and in promoting cancer cell invasion.

  • Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells. Vilpo, J.; Hulkkonen, J.; Hurme, M.; Vilpo, L. // Leukemia (08876924);Sep2002, Vol. 16 Issue 9, p1691 

    The factors determining the growth and survival of cells in B chronic lymphocytic leukemia (CLL) have remained poorly understood. We investigated the effects of optimal mitogen combinations (OMCs) on the expression of 26 surface membrane antigens among 33 CLL patients. The seven OMCs used were...

  • Doxorubicin/paclitaxel.  // Reactions Weekly;7/16/2011, Issue 1360, p17 

    The article describes the case of a woman who developed chronic lymphocytic leukaemia after receiving doxorubicin and paclitaxel for the treatment of breast carcinoma.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics